Curbstone Financial Management Corp Sells 136 Shares of Colgate-Palmolive Company $CL

Curbstone Financial Management Corp trimmed its holdings in Colgate-Palmolive Company (NYSE:CL) by 0.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,710 shares of the company’s stock after selling 136 shares during the period. Curbstone Financial Management Corp’s holdings in Colgate-Palmolive were worth $1,519,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Cornerstone Wealth Management LLC raised its holdings in shares of Colgate-Palmolive by 1.2% in the first quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company’s stock valued at $847,000 after purchasing an additional 110 shares during the last quarter. Grimes & Company Inc. raised its holdings in shares of Colgate-Palmolive by 1.0% in the second quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock valued at $1,136,000 after purchasing an additional 118 shares during the last quarter. RFG Advisory LLC raised its holdings in shares of Colgate-Palmolive by 1.4% in the second quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock valued at $839,000 after purchasing an additional 123 shares during the last quarter. Redhawk Wealth Advisors Inc. raised its holdings in shares of Colgate-Palmolive by 2.4% in the second quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock valued at $497,000 after purchasing an additional 129 shares during the last quarter. Finally, MONECO Advisors LLC raised its holdings in shares of Colgate-Palmolive by 2.2% in the first quarter. MONECO Advisors LLC now owns 6,051 shares of the company’s stock valued at $567,000 after purchasing an additional 133 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

CL opened at $79.14 on Friday. The company has a market capitalization of $63.96 billion, a price-to-earnings ratio of 22.23, a PEG ratio of 4.58 and a beta of 0.34. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. The firm has a 50-day moving average price of $81.96 and a 200-day moving average price of $87.39. Colgate-Palmolive Company has a twelve month low of $76.68 and a twelve month high of $100.54.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.03. The firm had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company’s revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the company earned $0.91 earnings per share. Equities analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.43%.

Wall Street Analysts Forecast Growth

CL has been the subject of several analyst reports. Wells Fargo & Company lowered their target price on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a report on Thursday, September 25th. The Goldman Sachs Group decreased their price objective on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a report on Thursday, October 2nd. Morgan Stanley decreased their price objective on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a report on Monday, August 4th. Citigroup decreased their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a report on Monday, August 4th. Finally, Bank of America decreased their price objective on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Eight research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $92.21.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.